ABSTRACT
Purpose
To develop and evaluate diagnostic tools for early detection of wear particle-induced orthopaedic implant loosening.
Methods
N-(2-Hydroxypropyl)methacrylamide (HPMA) copolymer was tagged with a near infrared dye and used to detect the inflammation induced by polymethylmethacrylate (PMMA) particles in a murine peri-implant osteolysis model. It was established by inserting an implant into the distal femur and challenging with routine PMMA particles infusion. The osteolysis was evaluated by micro-CT and histological analysis at different time points.
Results
Significant peri-implant osteolysis was found 3-month post PMMA particle challenge by micro-CT and histological analysis. At 1-month post challenge, when there was no significant peri-implant bone loss, the HPMA copolymer-near infrared dye conjugate was found to specifically target the femur with PMMA particles deposition, but not the contralateral control femur with phosphate buffered saline (PBS) infusion.
Conclusion
The results from this study demonstrate the feasibility of utilizing the macromolecular diagnostic agent to detect particle-induced peri-implant inflammation prior to the development of detectable osteolysis. Recognition of this early pathological event would provide the window of opportunity for prevention of peri-implant osteolysis and subsequent orthopaedic implant failure.
Similar content being viewed by others
Abbreviations
- APMA:
-
N-(3-aminopropyl)methacrylamide
- BS/TV:
-
Bone surface density
- BV:
-
Bone volume
- BV/TV:
-
Bone volume/tissue volume
- ELVIS:
-
Extravasation through leaky vasculature and inflammatory cell-mediated sequestration
- H&E:
-
Hematoxylin and eosin
- HPMA:
-
N-(2-Hydroxypropyl)methacrylamide
- i.S:
-
Intersection surface
- MMI:
-
Mean polar moment of inertia
- PBS:
-
Phosphate buffered saline
- P-IRDye:
-
PMA copolymer-near infrared dye conjugate
- PMMA:
-
Poly (methyl methacrylate)
- ROI:
-
Region of interest
- TRAP:
-
Tartrate-resistant acid phosphatase
- TV:
-
Tissue volume
- VOI:
-
Volume of interest
REFERENCES
Teeny SM, York SC, Mesko JW, Rea RE. Long-term follow-up care recommendations after total hip and knee arthroplasty: results of the American Association of Hip and Knee Surgeons’ member survey. J Arthroplast. 2003;18(8):954–62.
Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am Vol. 2007;89(4):780–5.
Meijer MF, Reininga IH, Boerboom AL, Stevens M, Bulstra SK. Poorer survival after a primary implant during revision total knee arthroplasty. Int Orthop. 2013;37(3):415–9.
Amstutz HC, Campbell P, Kossovsky N, Clarke IC. Mechanism and clinical significance of wear debris-induced osteolysis. Clin Orthop Relat Res. 1992;276:7–18.
Hallab NJ, Jacobs JJ. Biologic effects of implant debris. Bull NYU Hosp Jt Dis. 2009;67(2):182–8.
Holt G, Murnaghan C, Reilly J, Meek RM. The biology of aseptic osteolysis. Clin Orthop Relat Res. 2007;460:240–52.
Purdue PE, Koulouvaris P, Potter HG, Nestor BJ, Sculco TP. The cellular and molecular biology of periprosthetic osteolysis. Clin Orthop Relat Res. 2007;454:251–61.
Ingham E, Fisher J. The role of macrophages in osteolysis of total joint replacement. Biomaterials. 2005;26(11):1271–86.
Stulberg BN, Della Valle AG. What are the guidelines for the surgical and nonsurgical treatment of periprosthetic osteolysis? J Am Acad Orthop Surg. 2008;16 Suppl 1:S20–5.
Talmo CT, Shanbhag AS, Rubash HE. Nonsurgical management of osteolysis: challenges and opportunities. Clin Orthop Relat Res. 2006;453:254–64.
Malchau H, Potter HG. How are wear-related problems diagnosed and what forms of surveillance are necessary? J Am Acad Orthop Surg. 2008;16 Suppl 1:S14–9.
Beck RT, Illingworth KD, Saleh KJ. Review of periprosthetic osteolysis in total joint arthroplasty: an emphasis on host factors and future directions. J Orthop Res Off Publ Orthop Res Soc. 2012;30(4):541–6.
Saleh KJ, Thongtrangan I, Schwarz EM. Osteolysis: medical and surgical approaches. Clin Orthop Relat Res. 2004;427:138–47.
Potter HG, Nestor BJ, Sofka CM, Ho ST, Peters LE, Salvati EA. Magnetic resonance imaging after total hip arthroplasty: evaluation of periprosthetic soft tissue. J Bone Joint Surg Am Vol. 2004;86-A(9):1947–54.
Looney RJ, Boyd A, Totterman S, Seo GS, Tamez-Pena J, Campbell D, et al. Volumetric computerized tomography as a measurement of periprosthetic acetabular osteolysis and its correlation with wear. Arthritis Res. 2002;4(1):59–63.
Puri L, Wixson RL, Stern SH, Kohli J, Hendrix RW, Stulberg SD. Use of helical computed tomography for the assessment of acetabular osteolysis after total hip arthroplasty. J Bone Joint Surg Am Vol. 2002;84-A(4):609–14.
Ren K, Purdue PE, Burton L, Quan LD, Fehringer EV, Thiele GM, et al. Early detection and treatment of wear particle-induced inflammation and bone loss in a mouse calvarial osteolysis model using HPMA copolymer conjugates. Mol Pharm. 2011;8(4):1043–51.
Rao AJ, Nich C, Dhulipala LS, Gibon E, Valladares R, Zwingenberger S, et al. Local effect of IL-4 delivery on polyethylene particle induced osteolysis in the murine calvarium. J Biomed Mater Res A. 2012;101:1926–34.
Zhang X, Morham SG, Langenbach R, Young DA, Xing L, Boyce BF, et al. Evidence for a direct role of cyclo-oxygenase 2 in implant wear debris-induced osteolysis. J Bone Miner Res Off J Am Soc Bone Miner Res. 2001;16(4):660–70.
Yang SY, Yu H, Gong W, Wu B, Mayton L, Costello R, et al. Murine model of prosthesis failure for the long-term study of aseptic loosening. J Orthop Res: Off Publ Orthop Res Soc. 2007;25(5):603–11.
Epstein NJ, Warme BA, Spanogle J, Ma T, Bragg B, Smith RL, et al. Interleukin-1 modulates periprosthetic tissue formation in an intramedullary model of particle-induced inflammation. J Orthop Res: Off Publ Orthop Res Soc. 2005;23(3):501–10.
Zhang T, Yu H, Gong W, Zhang L, Jia T, Wooley PH, et al. The effect of osteoprotegerin gene modification on wear debris-induced osteolysis in a murine model of knee prosthesis failure. Biomaterials. 2009;30(30):6102–8.
Kopeček JBH. Poly[N-(2-hydroxypropyl)methacrylamide]—I. Radical polymerization and copolymerization. Eur Polym J. 1973;9(1):7–14.
Lai JT, Filla D, Shea R. Functional polymers from novel carboxyl-terminated trithiocarbonates as highly efficient RAFT agents. Macromolecules. 2002;35(18):6754–6.
Omelyanenko V, Kopeckova P, Gentry C, Kopecek J. Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate. J Control Release Off J Control Release Soc. 1998;53(1–3):25–37.
WH MSaS. A modified ninhydrin reagent for the photometric determination of amino acids and related compounds. J Biol Chem. 1954;211(2):907–13.
Yang SY, Mayton L, Wu B, Goater JJ, Schwarz EM, Wooley PH. Adeno-associated virus-mediated osteoprotegerin gene transfer protects against particulate polyethylene-induced osteolysis in a murine model. Arthritis Rheum. 2002;46(9):2514–23.
Noordin S, Masri B. Periprosthetic osteolysis: genetics, mechanisms and potential therapeutic interventions. Can J Surg J Can Chir. 2012;55(6):408–17.
Revell PA. The combined role of wear particles, macrophages and lymphocytes in the loosening of total joint prostheses. J R Soc Interface R Soc. 2008;5(28):1263–78.
Leopold SS, Rosenberg AG, Bhatt RD, Sheinkop MB, Quigley LR, Galante JO. Cementless acetabular revision. Evaluation at an average of 10.5 years. Clin Orthop Relat Res. 1999;369:179–86.
Ren W, Wu B, Peng X, Hua J, Hao HN, Wooley PH. Implant wear induces inflammation, but not osteoclastic bone resorption, in RANK(−/−) mice. J Orthop Res: Off Publ Orthop Res Soc. 2006;24(8):1575–86.
Quan LD, Purdue PE, Liu XM, Boska MD, Lele SM, Thiele GM, et al. Development of a macromolecular prodrug for the treatment of inflammatory arthritis: mechanisms involved in arthrotropism and sustained therapeutic efficacy. Arthritis Res Ther. 2010;12(5):R170.
Yuan F, Quan LD, Cui L, Goldring SR, Wang D. Development of macromolecular prodrug for rheumatoid arthritis. Adv Drug Deliv Rev. 2012;64(12):1205–19.
Shimizu T, Mehdi R, Yoshimura Y, Yoshikawa H, Nomura S, Miyazono K, et al. Sequential expression of bone morphogenetic protein, tumor necrosis factor, and their receptors in bone-forming reaction after mouse femoral marrow ablation. Bone. 1998;23(2):127–33.
Ma T, Huang Z, Ren PG, McCally R, Lindsey D, Smith RL, et al. An in vivo murine model of continuous intramedullary infusion of polyethylene particles. Biomaterials. 2008;29(27):3738–42.
Vermeirsch H, Nuydens RM, Salmon PL, Meert TF. Bone cancer pain model in mice: evaluation of pain behavior, bone destruction and morphine sensitivity. Pharmacol Biochem Behav. 2004;79(2):243–51.
Bellido M, Lugo L, Roman-Blas JA, Castaneda S, Caeiro JR, Dapia S, et al. Subchondral bone microstructural damage by increased remodelling aggravates experimental osteoarthritis preceded by osteoporosis. Arthritis Res Ther. 2010;12(4):R152.
Kolari PJ, Airaksinen O. Poor penetration of infra-red and helium neon low power laser light into the dermal tissue. Acupunct Electrother Res. 1993;18(1):17–21.
Mancini DM, Bolinger L, Li H, Kendrick K, Chance B, Wilson JR. Validation of near-infrared spectroscopy in humans. J Appl Physiol. 1994;77(6):2740–7.
Quan LD, Yuan F, Liu XM, Huang JG, Alnouti Y, Wang D. Pharmacokinetic and biodistribution studies of N-(2-hydroxypropyl)methacrylamide copolymer-dexamethasone conjugates in adjuvant-induced arthritis rat model. Mol Pharm. 2010;7(4):1041–9.
ACKNOWLEDGMENTS AND DISCLOSURES
This study was supported in part by NIH/NIAMS R01 AR053325 and R01 AR062680 to D.W. and an ACR-REF: Within Our Reach Grant to S.R.G. The authors would like to thank Ms. Laura Weber for proof-reading the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ren, K., Dusad, A., Zhang, Y. et al. Early Diagnosis of Orthopedic Implant Failure Using Macromolecular Imaging Agents. Pharm Res 31, 2086–2094 (2014). https://doi.org/10.1007/s11095-014-1310-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-014-1310-x